Chinese 3D printing technology startup Triastek has raised $15 million in Series A funding to accelerate the research and development of its 3D printed drugs. The funding round was led by fund managem…
Aspect Biosystems 3D Bioplinting选自2.2M癌症药物开发项目
Canadian 3D bioprinting technology company Aspect Biosystems has announced its involvement in a $2.2 million project seeking to find new treatments for cancer. Starting this year, the company will be …